Moderna (MRNA) PT Raised to $95 at BofA Securities
Tweet
Share
E-mail
Get Alerts MRNA Hot Sheet
Price: $64.46 --0%
Rating Summary:
5 Buy, 21 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 19
Rating Summary:
5 Buy, 21 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 19
Join SI Premium – FREE
BofA Securities analyst Geoff Meacham raised the price target on Moderna (NASDAQ: MRNA) to $95.00 (from $70.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Upgrades Americold Realty Trust (COLD) to Neutral
- MongoDB (MDB) PT Raised to $560 at Guggenheim
- Chubu Electric Power Company (9502:JP) (CHUEF) PT Raised to JPY3,130 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
